Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Annals of the New York Academy of Sciences|June 27, 2012
Abnormal intestinal permeability in Crohn's disease pathogenesisChristopher W Teshima, Levinus A Dieleman, Jon B MeddingsCurrent Gastroenterology Reports|September 19, 2008
The measurement and clinical significance of intestinal permeabilityChristopher W Teshima, Jon B MeddingsCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 15, 2009
Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohortChristopher W Teshima, Adrienne Thompson, LeRose Dhanoa, et al.Nutrients|October 9, 2019
The Gut Microbiota in Celiac Disease and probioticsRicha Chibbar, Levinus A DielemanBest Practice & Research. Clinical Gastroenterology|April 7, 2016
Prebiotics: Definition and protective mechanismsRosica Valcheva, Levinus A DielemanJournal of Clinical Gastroenterology|October 9, 2015
Probiotics in the Management of Ulcerative ColitisRicha Chibbar, Levinus A DielemanNederlands Tijdschrift Voor Geneeskunde|October 4, 2012
[Probiotics have a limited role in the treatment of inflammatory bowel disease]Levinus A Dieleman, Frank HoentjenWorld Journal of Gastroenterology|September 30, 2006
Probiotics and prebiotics in chronic inflammatory bowel diseasesJulia B Ewaschuk, Levinus A DielemanThe Journal of Nutrition|October 24, 2007
Inulin and oligofructose in chronic inflammatory bowel diseaseCeline H M Leenen, Levinus A DielemanFrontiers in Medicine|July 5, 2022
Manipulation of Gut Microbiota as a Key Target for Crohn's DiseaseReem Rashed, Rosica Valcheva, Levinus A DielemanPageof 16